Angelo Sambunaris
Psychiatry · Alpharetta, GANPI 1164541256
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $26,200 of the $32,678 with a category attached, or 80.2%. Janssen Research & Development, LLC accounts for 92.8% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $30,339 and has fallen 98.7% since, to $388 in 2025. Among psychiatry clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 82 payments — averaging $398.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Research & Development, LLC$30K
- Boehringer Ingelheim International GmbH$1K
- Johnson & Johnson$304
- Almatica Pharma LLC$249
- Axsome Therapeutics, Inc.$156
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$121
- plus $150 from 7 others
Across 292 payments — averaging $6809.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sage Therapeutics, LLC$657K
- AbbVie$377K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$362K
- Boehringer Ingelheim$275K
- Alkermes, Inc.$129K
- Merck$102K
- plus $87K from 4 others
What the payments were for
- Consulting fees$26,20080%
- Travel & lodging$4,43614%
- Food & beverage$2,0426%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Research & Development, LLC | 49 | $30,339 |
| Boehringer Ingelheim International GmbH | 1 | $1,360 |
| Johnson & Johnson | 5 | $304 |
| Almatica Pharma LLC | 14 | $249 |
| Axsome Therapeutics, Inc. | 3 | $156 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $121 |
| Supernus Pharmaceuticals, Inc. | 1 | $43 |
| Brainsway USA Inc | 1 | $29 |
| AbbVie | 1 | $17 |
| Eisai Inc. | 1 | $17 |
| Tempus AI, Inc | 1 | $15 |
| Merck | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$142
How this compares
$32,678 in reported general payments places this provider in the 95th percentile of 900 psychiatry providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lorazepam | 155 | $951 |
| Duloxetine Hcl | 46 | $858 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 40 | $673 |
| Olanzapine | 28 | $658 |
| Fluoxetine Hcl | 12 | $440 |
| Gabapentin | 15 | $217 |
| Alprazolam | 31 | $86 |
| Zolpidem Tartrate | 16 | $78 |
| Sertraline Hcl | 15 | $61 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Almatica Pharma LLCSertraline Hcl | $249 | $6115 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 900 psychiatry providers in Georgia.
Other psychiatry in Alpharetta
- Richard PettyLoganville$2.9M
- Ann GrooverCalhoun$1.4M
- Todd AntinDecatur$1M
- Michael BanovMarietta$733K
- Ben HunterBrookhaven$499K
- Joel MorganValdosta$337K
- Munjal ShroffSmyrna$316K
- David PurselleAtlanta$307K
- Jose CangianoAthens$244K
- Michael BurkeAtlanta$217K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.